Square Pharmaceuticals

Square Pharma posts Tk 600 crore profit in July-September

Square Pharmaceuticals PLC registered a 9 percent year-on-year growth in profit to Tk 600 crore in July-September this year.

Square Pharma makes Tk 1,491 crore profit in July-March

Square Pharmaceuticals Ltd clocked a Tk 1,491.01 crore profit in the July-March period of the ongoing financial year, up 4.9 per cent from a year earlier.

Renata’s Rajendrapur facility wins US FDA approval

Drug maker Renata Ltd has secured approval from the US Food and Drug Administration (USFDA) for its general facility in Rajendrapur.

Square Pharma gets nod for production in Kenyan factory

Square Pharmaceuticals Kenya EPZ Ltd, a subsidiary of Square Pharmaceuticals, has recently received a go-ahead to start commercial manufacturing in its Kenyan factory.

Square Pharma gets go-ahead to start manufacturing in Kenyan factory

The company will manufacture and sell generic pharmaceutical medicine in Kenya and East African Community (EAC).

November 15, 2023
November 15, 2023

Square Pharma posts Tk 600 crore profit in July-September

Square Pharmaceuticals PLC registered a 9 percent year-on-year growth in profit to Tk 600 crore in July-September this year.

May 2, 2023
May 2, 2023

Square Pharma makes Tk 1,491 crore profit in July-March

Square Pharmaceuticals Ltd clocked a Tk 1,491.01 crore profit in the July-March period of the ongoing financial year, up 4.9 per cent from a year earlier.

November 3, 2022
November 3, 2022

Renata’s Rajendrapur facility wins US FDA approval

Drug maker Renata Ltd has secured approval from the US Food and Drug Administration (USFDA) for its general facility in Rajendrapur.

June 1, 2022
June 1, 2022

Square Pharma gets nod for production in Kenyan factory

Square Pharmaceuticals Kenya EPZ Ltd, a subsidiary of Square Pharmaceuticals, has recently received a go-ahead to start commercial manufacturing in its Kenyan factory.

May 31, 2022
May 31, 2022

Square Pharma gets go-ahead to start manufacturing in Kenyan factory

The company will manufacture and sell generic pharmaceutical medicine in Kenya and East African Community (EAC).